This inventor holds 1 USPTO granted patent. Top assignees: Onyx Pharmaceuticals, Inc., Warner-Lambert Company. Active years: 2005.
Company Filing History:
1 out of 58 
1 out of 2,538 Years Active: 2005
Title: Edward H Walker: Innovator in Phosphoinositide Research
Introduction
Edward H Walker is a notable inventor based in Chesterton, GB. He has made significant contributions to the field of biochemistry, particularly in the study of phosphoinositide 3-kinases (PI3K). His work has implications for understanding various cellular processes and potential therapeutic applications.
Latest Patents
Edward H Walker holds a patent related to phosphoinositide 3-kinases. The patent encompasses PI3K crystals, polypeptide muteins, polypeptide fragments, antibodies, and nucleic acids coding for these polypeptides. It also details methods for modifying and modulating PI3Kγ activity, which includes aspects such as phospholipid binding, lipid kinase activity, and protein-protein interactions with PI3Kγ. He has been granted 1 patent for this innovative work.
Career Highlights
Throughout his career, Edward has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Onyx Pharmaceuticals, Inc. and Warner-Lambert Company. His experience in these organizations has contributed to his expertise in the field.
Collaborations
Edward has collaborated with esteemed colleagues, including Len Stephens and Christian Ried. These partnerships have likely enriched his research and development efforts in the area of phosphoinositide 3-kinases.
Conclusion
Edward H Walker's contributions to the field of biochemistry, particularly through his patent on phosphoinositide 3-kinases, highlight his role as an innovator. His work continues to influence research and potential applications in cellular biology.